debt_leverage_profile
0.36x Total Debt / Equity (Conservative)
High
SEC-XBRL
interest_rate_sensitivity
High sensitivity; ~CAD 500M long-term debt means 200bps rate rise adds ~CAD 10M annual interest burden, compressing already negative EBITDA further
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
1) Canadian cannabis cultivation regulation bottleneck; 2) German medical cannabis import licensing creating EU distribution chokepoint
Inferred
Agent_Inference
international_expansion_readiness
Exposed to EUR/CAD volatility (Germany ~20% intl revenue), GBP/CAD (UK ops), AUD/CAD (Australia); combined FX headwind risk ~5-8% revenue impact in CAD terms
Inferred
Agent_Inference
geographic_footprint
Primary markets: Canada (domestic), Germany (largest EU market), Australia and UK (secondary); EUR and GBP devaluation vs CAD poses moderate ~5-8% consolidated revenue risk
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
No single vendor exceeds 30% of input costs; cannabis cultivation is internally integrated, but packaging and extraction equipment suppliers carry moderate switching friction
Inferred
Agent_Inference
business_model_type_primary
Canopy is not meaningfully cloud-dependent for core operations; a cloud provider termination would disrupt ERP/CRM but not revenue generation; recovery feasible within 60-90 days
Inferred
Agent_Inference
business_model_type_secondary
Secondary digital operations (e-commerce, compliance reporting) could face 2-4 week disruption; no irreplaceable cloud-native revenue model exists
Inferred
Agent_Inference
switching_cost_profile
Minimal API coupling risk; Canopy's revenue model is physical product-based (cannabis cultivation, CPG); digital platform dependencies are standard off-the-shelf SaaS tools
Inferred
Agent_Inference
howey_test_risk_index
Low Howey Test risk; primary revenue from sale of cannabis goods and services constitutes commodity commerce, not investment contracts; securities law risk is negligible here
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Moderate GDPR exposure via German/EU medical patient data; CCPA exposure limited given small California footprint; compliance infrastructure exists but audit risk remains elevated
Inferred
Agent_Inference
antitrust_exposure_flag
Low antitrust risk; Canopy's Canadian market share has declined significantly (~10-15%); no dominant position in any legal cannabis jurisdiction currently
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
~85-90% transactional (wholesale and retail cannabis product sales); ~10-15% recurring via medical subscription patients and B2B supply agreements
Inferred
Agent_Inference
monetization_vector
Primary monetization via wholesale cannabis and derivative product sales to retailers and medical dispensaries; secondary via branded CPG (Tweed, Storz & Bickel devices)
Inferred
Agent_Inference
pricing_architecture
Pricing under significant pressure from illicit market and provincial retailer consolidation; premium brand pricing (Tweed, TWD) faces commodity compression; ~15-20% price erosion risk in stress scenario
Inferred
Agent_Inference
pricing_power_rating
Weak; 2/10 pricing power — commoditized cannabis market with illicit competition, provincial price controls, and retailer margin demands severely limit Canopy's pricing authority
Inferred
Agent_Inference
target_gross_margin_bracket
24.5% Gross Margin (Moderate (20-40%))
High
SEC-XBRL
churn_vulnerability_index
Significant free-rider/illicit market leakage; Canadian illicit cannabis market still ~40% of total consumption, structurally undermining legal market pricing and volume retention
Inferred
Agent_Inference
headcount_cost_structure
Revenue growth is largely sublinear to headcount given cultivation automation and prior massive restructuring (headcount cut ~70% 2020-2023); marginal production labor scales slowly
Inferred
Agent_Inference
marginal_cost_of_growth
Moderately favorable; cultivation capacity exists post-rationalization; incremental revenue can be added with ~30-40% marginal cost ratio if facilities are reactivated, but SG&A remains sticky
Inferred
Agent_Inference
franchise_compliance_risk
Not applicable; Canopy does not operate a franchise model
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, CAC economics remain challenged; cannabis retail is geographically constrained by regulation; digital acquisition channels limited by advertising restrictions in Canada and EU
Inferred
Agent_Inference
network_effect_present
No meaningful network effects; cannabis is a CPG category with brand loyalty but no platform dynamics; Storz & Bickel device ecosystem offers weak lock-in but not network effect
Inferred
Agent_Inference
asset_efficiency_ratio
-23.5% Return on Assets (Negative equity)
High
SEC-XBRL
recession_resistance_tier
Moderate recession resistance (Tier 2); cannabis shows some trading-down behavior but is discretionary; medical segment provides partial buffer; revenue declined during 2022-2023 macro stress
Inferred
Agent_Inference
customer_segment_primary
Canadian adult-use recreational consumers via provincial retailers (Ontario Cannabis Store, BCLDB); retailer concentration creates dependency — OCS alone ~25% of Canadian B2B volume
Inferred
Agent_Inference
customer_segment_secondary
Medical cannabis patients (Germany, Australia, Canada) and B2B wholesale buyers; German medical channel growing but still <20% of total revenue; no single secondary customer >15%
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
1.9% CapEx / Revenue (Low-CapEx Asset-Light)
High
SEC-XBRL
sec_cik
0001737927
High
SEC-EDGAR
ticker
CGC
High
SEC-EDGAR